NSE/ANTHEM (NSE/ANTHEM)

National Stock Exchange of India: NSE/ANTHEM · INR

₹833

-4.60 (-0.6%)· Recorded snapshot

Market cap	468.7B
Revenue (ttm)	20.1B
Net income (ttm)	5.8B
EPS (ttm)	₹10.1
Shares out	563.2M
P/E (trailing)	82.4x
P/E (forward)	62.4x
Dividend	₹2.00 (0.24%)
Volume	65,487

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.1B
Net income (ttm): 5.8B
EPS (ttm): ₹10.1
P/E (trailing): 82.4x
P/E (forward): 62.4x
Market cap: 468.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E62.4

P25 n/aP50 n/aP75 n/a

Trailing P/E82.4

P25 n/aP50 n/aP75 n/a

ROE21.7

P25 n/aP50 n/aP75 n/a

ROIC22.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/ANTHEM indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

INR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-10-28
Employees	2,282
Employees change	457
Employees growth	25.04%
Enterprise value	INR 459.8B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
ISIN number	INE0CZ201020
Last earnings date	2026-07-21
Last refreshed	2026-10-28
Market cap	INR 468.7B
Next earnings date	2026-10-28
Price	INR 832.55
Price currency	INR
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	nse/ANTHEM
Website	https://anthembio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.21%
EV/Earnings	79.84x
EV/EBIT	69.25x
EV/EBITDA	56.83x
EV/FCF	72.6x
EV/Sales	22.91x
FCF / EV yield	1.38%
FCF yield	1.35%
Forward P/E	62.4x
Graham number	110.98825
Graham upside	-86.67%
Industry forward P/E	44.35x
Industry P/E	94.47x
Lynch fair value	INR 252.69
Lynch upside	-69.65%
P/(FCF - SBC) ratio	75.9x
P/(OCF - SBC) ratio	56.56x
P/B ratio	15.4x
P/E ratio	82.37x
P/FCF ratio	74x
P/OCF ratio	55.5x
P/S ratio	23.35x
PEG ratio	3.12x
Price / tangible book value	15.41x
Price/EBITDA ratio	58.09x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.08%
EBITDA margin	40.19%
Effective tax rate	26.4%
FCF margin	29.74%
Gross margin	61.66%
Operating margin	33.08%
Pretax margin	38.99%
Profit margin	28.69%
Profit per employee	INR 2.5M
Profitable quarters	8
Profitable years	5
Revenue per employee	INR 8.8M
ROA	14.2%
ROA (5Y)	15.53%
ROCE	22.83%
ROE	21.71%
ROE (5Y)	25.38%
ROIC	22.65%
ROIC (5Y)	32.15%
SBC / revenue	0.74%
Tax / revenue	10.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.46%
EPS growth (Q)	-12.81%
EPS growth (QoQ)	-36.81%
EPS growth 3Y	26.77%
EPS growth years	2
FCF growth	6,678.51%
Gross profit growth	4.34%
Gross profit growth (Q)	-12.06%
Gross profit growth 3Y	24.48%
Net income growth	14.12%
Net income growth (Q)	-11.67%
Net income growth (QoQ)	-36.79%
Net income growth 3Y	28.52%
Net income growth years	2
OCF growth	212.14%
Operating income growth	2.03%
Operating income growth (Q)	-26.94%
Operating income growth 3Y	23.52%
Revenue growth	-2.18%
Revenue growth (Q)	-22.58%
Revenue growth (QoQ)	-32.1%
Revenue growth 3Y	22%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -2.1B
Depreciation and amortization	INR 1.4B
EBIT	INR 6.6B
EBITDA	INR 8.1B
EPS	INR 10.11
FCF per share	INR 11.25
Financing cash flow	INR -400M
Free cash flow	INR 6.3B
Free cash flow minus SBC	INR 6.2B
Gross profit	INR 12.4B
Income taxes	INR 2.1B
Investing cash flow	INR -7B
Net borrowing	INR -593.9M
Net cash flow	INR 1B
Net income	INR 5.8B
Operating cash flow minus SBC	INR 8.3B
Operating income	INR 6.6B
Revenue	INR 20.1B
Stock-based compensation	INR 158.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 54.16
Debt / EBITDA	0.07
Debt / equity	0.02
Debt / FCF	0.09
Interest coverage	114.13
Net cash (debt)	INR 8.8B
Net cash / market cap	1.89%
Net cash growth	42.91%
Net debt / EBITDA	-1.1
Net debt / equity	-0.29
Net debt / FCF	-1.4
Piotroski F-Score	6
Shareholders' equity	INR 30.4B
Tangible book value	INR 30.4B
Tangible book value per share	INR 54.16
Total cash	INR 9.4B
Total debt	INR 539.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.68
Current ratio	5.54
Inventory turnover	3.68
Quick ratio	4.7
Working capital	INR 14.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.42%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-21
Dividend payment years	1
Dividend per share	INR 2.00
Dividend yield	0.24%
Ex-dividend date	2026-06-25
FCF payout ratio	17.79%
Last dividend	INR 2.00
Payout ratio	19.79%
Shareholder yield	-1.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 803.45
1D price change	-0.55%
1M price change	-4.7%
1M total return	-4.7%
1W price change	2.98%
1W total return	2.98%
1Y price change	13.87%
1Y return CAGR	14.18%
1Y total return	14.17%
20-day SMA	INR 846.66
200-day SMA	INR 764.67
3M price change	5.31%
3M total return	5.31%
50-day SMA	INR 884.37
50-day SMA vs 200-day SMA	50over200
52-week high	INR 977.55
52-week high date	2026-09-09
52-week low	INR 579.15
52-week low date	2026-02-02
6M price change	8.16%
6M total return	8.44%
All-time high	INR 977.55
All-time high date	2026-09-09
All-time low	INR 579.15
All-time low date	2026-02-02
Average true range (ATR)	INR 26.59
Average volume	399.8K
Beta (1Y)	0.56
Beta (2Y)	0.54
Change from 52-week high	-14.83%
Change from 52-week low	43.75%
Change from all-time high	-14.83%
Change from all-time low	43.75%
Change from open	-0.17%
Day's gap	-0.38%
Dollar volume	INR 54.5M
High price	INR 836.55
Low price	INR 827.05
Monthly RSI	51.99
Open price	INR 834.00
Position in 52-week range	57.89%
Previous close	INR 837.15
Price vs 150-day SMA	3.62%
Price vs 20-day SMA	-1.67%
Price vs 200-day SMA	8.88%
Price vs 50-day SMA	-5.86%
Relative volume	0.16
RSI	43.7
Sharpe ratio	0.48
Sortino ratio	0.97
Volume	65.5K
Weekly RSI	52.36
YTD price change	27.79%
YTD total return	28.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72.1M
Shares change (QoQ)	0.05%
Shares change (YoY)	1.42%
Shares held by insiders	78.66%
Shares held by institutions	14.47%
Shares outstanding	563.2M

Deeper analysis on NSE/ANTHEM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/ANTHEM report

Is a complete NSE/ANTHEM research report available?

No complete published report is available for nse/ANTHEM (NSE/ANTHEM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/ANTHEM (NSE/ANTHEM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/ANTHEM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/ANTHEM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/ANTHEM

Frequently asked questions